Company Filing History:
Years Active: 2025
Title: Thomas Leischner: Innovator in Iridium Catalysts
Introduction
Thomas Leischner is a notable inventor based in Rostock, Germany. He has made significant contributions to the field of chemistry, particularly in the development of new catalysts for chemical processes. His work focuses on enhancing the efficiency and selectivity of hydrogenation reactions.
Latest Patents
Leischner holds a patent for a process that utilizes new iridium catalysts for the enantioselective hydrogenation of 4-substituted 1,2-dihydroquinolines. This invention relates to a method for preparing optically active 4-substituted 1,2,3,4-tetrahydroquinolines through the enantioselective hydrogenation of the corresponding 4-substituted 1,2-dihydroquinolines in the presence of a chiral iridium (P,N)-ligand catalyst. He has 1 patent to his name.
Career Highlights
Leischner is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to explore innovative solutions in catalysis and chemical synthesis.
Collaborations
Throughout his career, Thomas Leischner has collaborated with esteemed colleagues such as Christoph Schotes and Matthias Beller. These collaborations have further enriched his research and contributed to advancements in the field.
Conclusion
Thomas Leischner is a prominent figure in the realm of chemical innovation, particularly known for his work on iridium catalysts. His contributions continue to influence the field of enantioselective hydrogenation, showcasing the importance of innovation in chemistry.